Remedy Pharmaceuticals Receives $9,000,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e5e41ab7-5311-4771-8b20-b26552b1e2ea
Date
12/1/2015
Company Name
Remedy Pharmaceuticals
Mailing Address
122 West 27th Street 10th Floor New York, NY 10001 USA
Company Description
Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury.
Website
http://www.remedypharmaceuticals.com
Transaction Type
Venture Equity
Transaction Amount
$9,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Funds will be used to accelerate the company’s pathway to a phase 3 study in severe stroke.
M&A Terms
Venture Investor
The Vertical Group
Venture Investor
Undisclosed